Stock comparison
Haemonetics
Galapagos N.V. Sponsored ADR
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HAE
Haemonetics
Market cap
$2.98B
Sector
Healthcare
LKFT
Galapagos N.V. Sponsored ADR
Market cap
$1.81B
Sector
Healthcare
Overall winner
Haemonetics HAE
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HAE | LKFT | Winner |
|---|---|---|---|
| Warren Buffett | 70B | 46D | HAE |
| Benjamin Graham | 85A | 45D | HAE |
| Philip Fisher | 60C | 53C | HAE |
| Peter Lynch | 54C | 60C | LKFT |
| Joel Greenblatt | 31F | 42D | LKFT |
| Charlie Munger | 54D | 46D | HAE |
| Terry Smith | 55D | 46D | HAE |
Side-by-side metrics
| Metric | HAE | LKFT |
|---|---|---|
| Market cap | $2.98B | $1.81B |
| P/E (TTM) | 24.8x | 3.1x |
| EV/EBIT | 14.1x | 2.9x |
| ROIC (TTM) | 8.37% | 18.22% |
| Gross margin | 55.74% | 98.01% |
| Net margin | 7.29% | 46.83% |
| Revenue CAGR 5y | 7.65% | - |
| EPS CAGR 5y | 24.62% | - |
| Debt / Equity | 1.5x | 0.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HAE leads on
- Market cap$2.98Bvs $1.81B+39%
LKFT leads on
- Debt / Equity0.0xvs 1.5x+100%
- P/E (TTM)3.1xvs 24.8x+87%
- Net margin46.83%vs 7.29%+84%
- EV/EBIT2.9xvs 14.1x+79%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.